2seventy bio, Inc. (NASDAQ:TSVT) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the 2seventy bio Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
2Seventy Bio Inc. (TSVT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kynam Capital Derrick Tang | 5,953,825 | $28,102,054 | 2.15% | |
| 2. | Madison Avenue Partners Eli Samaha | 2,563,222 | $12,098,408 | 1.12% | |
| 3. | Newtyn Management Noah Levy And Eugene Dozortsev | 2,540,000 | $11,988,800 | +3% | 1.84% |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,497,526 | $11,788,323 | 0.12% | |
| 5. | Casdin Capital Eli Casdin | 2,000,000 | $9,440,000 | 0.62% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.10 | 40,000 | Director | 2,000,000 | 2024-03-26 | Filing | |
| $5.07 | 330,000 | Director | 1,960,000 | 2024-03-25 | Filing | |
| $5.12 | 147,377 | Director | 1,630,000 | 2024-03-22 | Filing | |
| $4.90 | 300,000 | Director | 1,482,623 | 2024-03-21 | Filing | |
| $5.96 | 86,414 | Large Shareholder | 5,142,111 | 2023-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.23 | 2,287 | 153,479 | 2024-12-13 | Filing | ||
| $3.38 | 3,900 | 23,752 | 2024-11-18 | Filing | ||
| $4.65 | 679 | 155,766 | 2024-10-03 | Filing | ||
| $4.65 | 1,230 | 340,089 | 2024-10-03 | Filing | ||
| $4.32 | 7,816 | 156,330 | 2024-08-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,842,810 | $20,678,800 | 0% | |
| 2. | 4,508,800 | $19,252,576 | 0% | |
| 3. | 3,985,770 | $17,019,237 | 0% | |
| 4. | 3,911,724 | $16,703,061 | 0% | |
| 5. | 1,331,801 | $5,686,790 | 0.54% |
News See All
2seventy bio, Inc. (NASDAQ:TSVT) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the 2Seventy Bio Second Quarter 2024 Earnings Conference Call.
5 Penny Stocks with Insider Buying in 2024
Biotech company 2Seventy Bio Inc (NASDAQ:TSVT) saw heavy insider buying activity earlier this year when Casdin Capital, LLC, which has a director status at 2Seventy Bio Inc (NASDAQ:TSVT), bought 777...
2seventy bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript
2seventy bio, Inc. misses on earnings expectations. Reported EPS is $-0.81 EPS, expectations were $-0.72.
2seventy bio, Inc. (NASDAQ:TSVT) Q4 2023 Earnings Call Transcript
2seventy bio, Inc. beats earnings expectations. Reported EPS is $-1.11, expectations were $-1.22.
10 Stocks That Are About To Explode
The stock market has been quite tumultuous recently.
5 Oversold Small Cap Stocks To Buy
In this piece, we will take a look at the five oversold small cap stocks to buy.
Billionaire Hedge Funds
